Back to search

Article

Active growth signalling promotes cancer cell sensitivity to the CDK7 inhibitor ICEC0942

2021-09-10

Abstract excerpt

CDK7 has a central role in promoting cellular proliferation, through the activation of the mitotic CDKs, and by driving global gene expression, through targeting RNA polymerase II. Several recently developed CDK7 inhibitors (CDK7i) have been shown to be non-toxic and to limit tumour growth for a number of cancer cell types and are now in Phase I/II clinical trials. However, the mechanisms underlying the sensitivit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e12f663-e148-542f-bead-ee378624824f
DOI
10.1101/2021.09.10.459733
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Active growth signalling promotes cancer cell sensitivity to the CDK7 inhibitor ICEC0942DOI 10.1101/2021.09.10.459733
Select a neighboring publication to make it the new centre.